Antheia raises $17M for biomanufacturing platform and outlines spending plan

Antheia raises $17M in Funding for Biomanufacturing Platform

Antheia (Linkedin), a biotechnology research company based in the United States, secured $17 million in funding to advance their innovative whole-cell engineering approach for agile and resilient biomanufacturing of critical pharmaceutical ingredients. They are seeking partnerships with pharmaceutical companies, healthcare providers, and research organizations to revolutionize the healthcare industry.

Funding Amount: $17 million

Industry: Biotechnology Research

Employee Count: 11-50

CEO: Christina Smolke (CEO Linkedin)

What Antheia needs to buy: Manufacturing equipment and facilities, research and development partnerships, and marketing and sales support are key areas where Antheia is looking for collaboration. Companies specializing in biomanufacturing technology, research and development, and marketing services can help Antheia scale their operations, expand their product offerings, and establish a strong market presence.